We are live on ! Find out more
RFA

Reilly Financial Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+22.65%
3 Year Est. Return
+99%
5 Year Est. Return
+129.17%
10 Year Est. Return
AUM
$1.35B
AUM Growth
+$171M
Cap. Flow
+$72.5M
Cap. Flow %
5.38%
Top 10 Hldgs %
24.42%
Holding
1,237
New
296
Increased
234
Reduced
184
Closed
72

Top Buys

Rank Stock Value
1
SONY icon
Sony
SONY
+$22.9M
2
TD icon
Toronto Dominion Bank
TD
+$19.5M
3
CARR icon
Carrier Global
CARR
+$18.9M
4
ENB icon
Enbridge
ENB
+$17.5M
5
CTLT
CATALENT, INC.
CTLT
+$16.8M

Top Sells

Rank Stock Value
1
ERIC icon
Ericsson
ERIC
+$15.6M
2
HDB icon
HDFC Bank
HDB
+$14.5M
3
ENS icon
EnerSys
ENS
+$12M
4
CTKB icon
Cytek Biosciences
CTKB
+$10.6M
5
D icon
Dominion Energy
D
+$8.15M

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Financials 13%
3 Healthcare 12.02%
4 Miscellaneous 11.28%
5 Consumer Discretionary 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGO icon
1101
Winnebago Industries
WGO
$762M
$1K ﹤0.01%
10
XPO icon
1102
XPO
XPO
$20.5B
$1K ﹤0.01%
+30
New +$1.39K
INVX
1103
Innovex International
INVX
$2.04B
$1K ﹤0.01%
+50
New +$1.1K
DGXX
1104
Digi Power X Inc
DGXX
$389M
$1K ﹤0.01%
+166
New +$818
AKTS
1105
DELISTED
Akoustis Technologies Inc
AKTS
$1K ﹤0.01%
+180
New +$1.34K
ME
1106
DELISTED
23andMe Holding Co
ME
$1K ﹤0.01%
+5
New +$923
DMTK
1107
DELISTED
DermTech, Inc. Common Stock
DMTK
$1K ﹤0.01%
+70
New +$1.68K
GOEV
1108
DELISTED
Canoo Inc. Class A Common Stock
GOEV
0
CHS
1109
DELISTED
Chicos FAS, Inc.
CHS
$1K ﹤0.01%
100
BIOC
1110
DELISTED
Biocept, Inc.
BIOC
$1K ﹤0.01%
+7
New +$806
PRVB
1111
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
+200
New +$1.27K
COUP
1112
DELISTED
Coupa Software Incorporated
COUP
$1K ﹤0.01%
+5
New +$1.03K
CDK
1113
DELISTED
CDK Global, Inc.
CDK
$1K ﹤0.01%
25
ZNGA
1114
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1K ﹤0.01%
100
MFGP
1115
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$1K ﹤0.01%
+170
New +$865
ABUS icon
1116
Arbutus Biopharma
ABUS
$1B
$0 ﹤0.01%
+75
New +$291
ADC icon
1117
Agree Realty
ADC
$8.48B
-250
Closed -$40K
AKO.A icon
1118
Embotelladora Andina Series A
AKO.A
$3.66B
-85
Closed -$1K
ANF icon
1119
Abercrombie & Fitch
ANF
$5.88B
$0 ﹤0.01%
9
ASIX icon
1120
AdvanSix
ASIX
$453M
$0 ﹤0.01%
2
BNED icon
1121
Barnes & Noble Education
BNED
$370M
0
BPT
1122
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$0 ﹤0.01%
50
BROS icon
1123
Dutch Bros
BROS
$5.54B
$0 ﹤0.01%
3
BWX icon
1124
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
-452
Closed -$13K
BXC icon
1125
BlueLinx
BXC
$588M
-8
Closed

Similar funds

Reilly Financial Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Reilly Financial Advisors held 1,237 positions worth $1.35B, up 15% from $1.18B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Reilly Financial Advisors deployed $72.5M of net new capital in Q4 2021, opening 296 new positions and adding to 234 existing holdings. Its largest new stake was Sony: 960,090 shares worth $24.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Ericsson, an estimated $15.6M trimmed.

  • Reilly Financial Advisors's largest Q4 2021 buy was Sony: 960,090 shares worth $24.3M.
  • Reilly Financial Advisors added most to Toronto Dominion Bank in Q4 2021, an estimated $19.5M increase.
  • Reilly Financial Advisors's biggest Q4 2021 reduction was Ericsson, cutting an estimated $15.6M.
  • Reilly Financial Advisors fully exited Cytek Biosciences in Q4 2021, selling an estimated $10.6M.
  • Reilly Financial Advisors's ten largest holdings make up 24% of its $1.35B portfolio in Q4 2021.
  • Reilly Financial Advisors opened 296 new positions and closed 72 in Q4 2021.
  • Reilly Financial Advisors's portfolio value rose 15% quarter-over-quarter to $1.35B.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.